TP53 structural variants in metastatic prostatic carcinoma.

by Deepika Sirohi, Patrick Devine, James P Grenert, Jessica van Ziffle, Jeffry P Simko, Bradley A Stohr
Published 2019-01-01

A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer

by Clinton L. Cario, Emmalyn Chen, Lancelote Leong, Nima C. Emami, Karen Lopez, Imelda Tenggara, Jeffry P. Simko, Terence W. Friedlander, Patricia S. Li, Pamela L. Paris, Peter R. Carroll, John S. Witte
Published 2020-08-01

Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients

by Jeffrey Belkora, June M. Chan, Matthew R. Cooperberg, John Neuhaus, Lauren Stupar, Tia Weinberg, Jeanette M. Broering, Imelda Tenggara, Janet E. Cowan, Stan Rosenfeld, Stacey A. Kenfield, Erin L. Van Blarigan, Jeffry P. Simko, John Witte, Peter R. Carroll
Published 2020-01-01

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

by Emmalyn Chen, Clinton L. Cario, Lancelote Leong, Karen Lopez, César P. Márquez, Carissa Chu, Patricia S. Li, Erica Oropeza, Imelda Tenggara, Janet Cowan, Jeffry P. Simko, June M. Chan, Terence Friedlander, Alexander W. Wyatt, Rahul Aggarwal, Pamela L. Paris, Peter R. Carroll, Felix Feng, John S. Witte
Published 2021-03-01